The spinal cord is a bundle of nerves inside the spine that gives your body structure and support. Spinal cord injuries (SCIs) tend to be devastating and most are permanent. Recent research has shown that motor neuron obtained from skin cells could serve as potential treatments for spinal cord injuries, and thus has received considerable research attention. With this, a new door has been opened for treating not only spinal cord injuries, caused by workplace accidents and car crashes, but also Lou Gehrigs disease, known as amyotrophic lateral sclerosis or ALS.
A research team, led by Professor Jeong Beom Kim and his research team in the School of Life Sciences at UNIST has demonstrated that human fibroblasts can be converted into induced motor neurons (iMNs) by sequentially inducing two transcription factors, POU5F1(OCT4) and LHX3. The research team further investigated the therapeutic effects of iMNs for treating traumatic spinal cord injury using rodent spinal cord injury model. Their findings indicate that the sequential induction of two transcription factors is essential for generating self-renewing iMNICs more efficiently. This method not only ensures large-scale production of pure iMNs, but also facilitates the feasibility of iMNs for SCI treatment.
The spinal cord is responsible for transmitting signals from the brain to the rest of the body, and vice versa. Along with motor and sensory deficits, damage to the spinal cord can cause long-term complications, including limited mobility. Although there are many treatment options available for people with SCI, most of them have adverse side effects that impact therapy. And this is why stem cell (SC) therapies to restore functions of damaged tissues are attracting attention, recently. Among those cells constituting the spinal cord, motor neurons that involved in the regulation of muscle function have emerged as a promising candidate for the stem cell-based therapy for SCIs. Despite these encouraging advances, ethical issue of embryonic stem cells (ESCs) and tumorigenic potential of induced pluripotent stem cells (iPSCs) have impeded their translations into clinical trials.
Figure 1. The experimental scheme for the generation of induced motor neurons (iMNs) from human fibroblasts via sequential transduction of two transcription factors.
To overcome these limitations, Professor Kim and his research team established an advanced direct conversion strategy to generate iMNs from human fibroblasts in large-scale with high purity, thereby providing a cell source for the treatment of SCI. These iMNs possessed spinal cord motor neuronal identity and exhibit hallmarks of spinal MNs, such as neuromuscular junction formation capacity and electrophysiological properties in vitro. Importantly, their findings also show that transplantation of iMNs improved locomotor function in rodent SCI model without tumor formation. According to the research team, This proof-of-concept study shows that our functional iMNs can be employed to cell-based therapy as an autologous cell source. Through this, they resolved the problem of immune rejection, and thus reduce the risk of cancer.
In the study, we succeeded in generating iMNs from human fibroblasts by overexpressing POU5F1(OCT4) and LHX3, says Hyunah Lee (Combined MS/Ph.D program of Life Sciences, UNIST), the first author of the study.
Figure 2. Therapeutic effects of iMNs in rat spinal cord injury model in vivo. (A) The position of hindlimbs in control rat and iMN-transplanted rat after 8 weeks of transplantation. (B) C staining analysis of spinal cords after 8 weeks of transplantation (I; Control, J; iMN-transplanted).
The developed motor nerve cell manufacturing method has the advantage of being capable of mass production. A sufficient amount of cells is required for patient clinical treatment, but the existing direct differentiation technique has limited the number of cells that can be obtained. On the other hand, the method developed by the research team is capable of mass production because it undergoes an intermediate cell stage capable of self-renewal. After injecting the produced cells into the spinal cord injury mice, it was confirmed that the lost motor function is restored and the nerves are regenerated in the damaged spinal cord tissue.
Although further investigation on mechanism responsible for cell fate conversion may be needed, our strategy is a safer and simpler methodology that may provide new insights to develop personalized stem cell therapy and drug screening for MN diseases or spinal cord disorders, says Professor Kim. If combined with SuPine Patch, an adhesive hydrogel patches with the purpose of regenerating the damaged spinal cords, its therapeutic effects will be maximized. He adds, As the incidence of spinal cord injury is high due to industrial accidents, synergistic effects with public hospitals specializing in industrial accidents scheduled to be built in Ulsan should be expected.
This study has been jointly carried out with Professor Kims startup company, SuPine Therapeutics Inc. with the support of the Ministry of SMEs and Startups (MSS). The findings of this research have been published in the 2020 June issue of the online edition of eLife, a renowned academic journal of the European Molecular Biology Organizationl (EMBO).
Journal Reference
Hyunah Lee, Hye Yeong Lee, Byeong Eun Lee, et al., Sequentially induced motor neurons from human fibroblasts facilitate locomotor recovery in a rodent spinal cord injury model, eLife, (2020).
Go here to see the original:
New Study Presents Cell-based Therapy for MN Diseases or Spinal Cord Disorders - Mirage News
- Global Stem Cell Technologies and Applications Market 2020-2030 - GlobeNewswire - April 16th, 2021
- Global Human Embryonic Stem Cells Industry Market 2021 In-depth Industry Analysis, Growth By 2027:Lonza Group Ltd., Life Technologies Corporation,... - April 6th, 2021
- Human Embryonic Stem Cells (HESC) Market 2021 Is Rapidly Increasing Worldwide in Near Future | Top Companies Analysis- ESI BIO, Thermo Fisher,... - April 6th, 2021
- Scientists grow and observe mouse embryos outside the womb - ISRAEL21c - April 6th, 2021
- New Michigan law requires those receiving Johnson & Johnson vaccine be told it was developed using stem cells | TheHill - The Hill - April 6th, 2021
- Stem Cell Therapy Market Latest Innovations and Trends to Boost Growth during 2021-2028 | Astellas Pharma Inc, Cellular Engineering Technologies,... - April 6th, 2021
- Xenobots 2.0 are Here and Still Developed With Frog Stem Cells - Unite.AI - April 6th, 2021
- Induced Pluripotent Stem Cells Market Exclusive insight on Transformation 2029 SoccerNurds - SoccerNurds - March 29th, 2021
- Human Embryonic Stem Cells | The Embryo Project Encyclopedia - March 24th, 2021
- Sydney archbishop urges 'deep breath' after news of artificial embryos - Long Island Catholic - March 24th, 2021
- Researchers grow mouse embryos outside the uterus to reveal hidden growth stages - SlashGear - March 20th, 2021
- Industry Overview of Stem Cell Treatments: Market Report Based on Development, Scope, Share, Trends, Forecast to 2026 SoccerNurds - SoccerNurds - March 15th, 2021
- A Genetic Curse, a Scared Mom, and the Quest to 'Fix' Embryos - WIRED - March 13th, 2021
- Deciphering epiblast lumenogenesis reveals proamniotic cavity control of embryo growth and patterning - Science Advances - March 11th, 2021
- Promising stem-cell based drug for treatment of ALS receives patent - The Jerusalem Post - March 11th, 2021
- Human embryo research beyond the primitive streak - Science Magazine - March 11th, 2021
- Detroit mayor turned down J&J vaccine in favor of others - WCNC.com - March 11th, 2021
- 14 Advantages and Disadvantages of Embryonic Stem Cell ... - March 7th, 2021
- Embryonic stem cell | biology | Britannica - March 7th, 2021
- Is the coronavirus vaccine made from fetal cell lines? - March 7th, 2021
- Effect of Nanog overexpression on the metastatic potential of a mouse melanoma cell line B16-BL6 - DocWire News - March 7th, 2021
- Gene behind third of cancers turned off by scientists - Yahoo Sports - March 3rd, 2021
- Comprehensive Report on Human Embryonic Stem Cells Market 2021 | Size, Growth, Demand, Opportunities & Forecast To 2027 | CellTherapies P/L,... - March 3rd, 2021
- Stem Cell Therapy Market 2021 Global Industry Size, Reviews, Segments, Revenue, and Forecast to 2027 NeighborWebSJ - NeighborWebSJ - March 1st, 2021
- Innovative Stem Cells Market Research Report Segmented by Applications, Geography, Trends and Projection 2026 Express Keeper - Express Keeper - March 1st, 2021
- Human Embryonic Stem Cells Industry Market 2021 Overview, Opportunities, In-Depth Analysis by 2027:Lonza Group Ltd., Life Technologies Corporation,... - February 25th, 2021
- Stem Cell Therapy Market Size 2021 | Analysis, Regional Outlook, Competitive Strategies And Forecast up to 2027 - NY Market Reports - February 25th, 2021
- Global Cell Freezing Media for Cell Therapy Market Size, Analysis, Growth ratio, Top Players and Fut - PharmiWeb.com - February 25th, 2021
- The Very First Signs of an Immune Response Have Been Filmed in a Developing Embryo - ScienceAlert - February 14th, 2021
- Outlook on the Cell Therapy Global Market to 2027 - Opportunity Analysis and Industry Forecasts - Yahoo Eurosport UK - February 10th, 2021
- Translational Regenerative Medicine Market: Immunotherapy is projected to be the fastest growing segment during the forecast period - BioSpace - February 10th, 2021
- Study identifies major flaws in iBMEC-based models of the blood-brain barrier - News-Medical.Net - February 10th, 2021
- Harnessing the Potential of Cell and Gene Therapy - OncLive - February 5th, 2021
- When scientific data is too good to be true - Haaretz - February 5th, 2021
- Global Human Embryonic Stem Cells Market increasing demand with Industry Professionalist |know the Brand Players forecast 2027 Jumbo News - Jumbo... - February 5th, 2021
- Should We Double The Age When Science Can Experiment On Babies? - 550 KTSA - February 5th, 2021
- Push on to Allow Expanded Human-Embryo Research - National Review - February 3rd, 2021
- Missouri State Representative Indicted Over Alleged Stem Cell Therapy Scam - IFLScience - February 3rd, 2021
- ToolGen ties up with 3D bioprinting company to apply induced pluripotent stem cells to gene correction - Aju Business Daily - February 3rd, 2021
- Stem Cells Market is Expected to Thrive at Impressive CAGR by 2025 Murphy's Hockey Law - Murphy's Hockey Law - February 3rd, 2021
- Louisiana Right to Life: COVID-19 vaccines and abortion - The Baptist Message - January 16th, 2021
- Organoids show how mutations in top autism gene may lead to brain overgrowth in people - Spectrum - January 16th, 2021
- Reversing The Aging Clock With Epigenetic Reprogramming - Bio-IT World - January 16th, 2021
- Global Stem Cell Therapy Market Report 2020: Market to Recover and Reach $14.76 Billion in 2023 at a CAGR of 19.62% - Forecast to 2030 - Yahoo Finance - January 8th, 2021
- Factor Bioscience spins out a new cell therapy player with eyes on the clinic within 2 years - Endpoints News - January 8th, 2021
- 'He was very honored in his work' - Mercer Island Reporter - December 28th, 2020
- Stem Cell Assay Market In-Depth Analysis and Forecast 2017-2025 - NeighborWebSJ - December 25th, 2020
- Israeli biotech firm's ALS treatment shows safety of use in trials - The Jerusalem Post - December 18th, 2020
- Ca Bishops To Work w/ Govt on Vaccination Campaigns - Catholic Herald Online - December 15th, 2020
- Advanced Therapy Medicinal Products Market 2019 Global Industry Analysis By Size, Share, Trends and - PharmiWeb.com - December 10th, 2020
- Accelerating Sales in North America to Drive the Stem Cell Therapy market between 2020 and 2030 - Cheshire Media - December 3rd, 2020
- Human Embryonic Stem Cells Market in Global : Current and the Future Trends: Astellas Pharma Inc/ Ocata Therapeutics, Stemcell Technologies Inc - The... - December 3rd, 2020
- Stem Cells Market Size on Target to Reach US$ 17.79 Billion 2027 - Cheshire Media - December 3rd, 2020
- GFI1: New Role Uncovered for a Protein Involved in Hearing : The Hearing Journal - LWW Journals - December 3rd, 2020
- Human Embryonic Stem Cells (HESC) Market 2019 | Analyzing The Impact Followed By Restraints, Opportunities And Projected Developments | DataIntelo -... - December 1st, 2020
- Stem Cell Manufacturing Market Analysis by Industry Size, Share, Key Drivers, Growth Factors, Demands, Top Manufacturers- Merck Group, Becton,... - December 1st, 2020
- Stem Cells Market is Expected to Thrive at Impressive CAGR by 2025 - The Haitian-Caribbean News Network - December 1st, 2020
- This Date in UCSF History: Election Offers Mixed Bag of Results - Synapse - December 1st, 2020
- Stem Cell Therapy Market Research Report Forecast to 2029 (Includes Business Impact of COVID-19) - Cheshire Media - December 1st, 2020
- Stem Cell Assay to Register Substantial Expansion by 2026| Merck, Thermo Fisher Scientific, GE Healthcare - The Haitian-Caribbean News Network - December 1st, 2020
- Autism genes affect development of neurons and glia - Spectrum - November 28th, 2020
- Stem Cell Medical Research to Expand in California Following Passage of Prop. 14 - Times of San Diego - November 28th, 2020
- TRF2-mediated telomere protection is dispensable in pluripotent stem cells - Nature.com - November 26th, 2020
- Stem Cell Therapy Global Market Report 2020-30: Covid 19 Growth and Change - Yahoo Finance UK - November 26th, 2020
- Stem Cells Market 2020: Rising with Immense Development Trends across the Globe by 2027 - The Market Feed - November 26th, 2020
- Stem Cell Characterization and Analysis Tool Market 2020: Potential growth, attractive valuation make it is a long-term investment | Know the COVID19... - November 26th, 2020
- Global Regenerative Medicine Market 2020-2025: Opportunities with the Implementation of the 21st Century Cures Act - Yahoo Eurosport UK - November 26th, 2020
- Mount Sinai Cardiologist Awarded $2.9 Million NIH Grant to Advance Work with Stem Cells and Heart Repair after Heart Attack - Cath Lab Digest - November 25th, 2020
- Dr. David Steenblock - Stem Cells and Regenerative Medicine - BlogTalkRadio - November 25th, 2020
- Breakthroughs in Stem Cell Based Treatment of Heart Disease - The Connecticut College Voice - November 25th, 2020
- Stem Cell Therapy Market To Observe Exponential Growth By 2020-2027 | Reports Globe - Cheshire Media - November 25th, 2020
- The Stem Cell Characterization and Analysis Tools Market to grow incomparably in the next decade - The Market Feed - November 25th, 2020
- University of Alberta research team poised to cure diabetesagain - Wetaskiwin Times Advertiser - November 23rd, 2020
- New Role For Serotonin Identified In The Evolution Of The Developing Brain - Anti Aging News - November 18th, 2020
- AgeX Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update - Business Wire - November 18th, 2020
- Stem Cell Banking Market is Projected to Reach $6,956 million by 2023 | Leading key players are Cord Blood Registry, ViaCord, Cryo-Cell, China Cord... - November 14th, 2020
- California approves billions for stem-cell research - Modern Healthcare - November 14th, 2020
- Cell Freezing Media for Cell Therapy Market 2020 Strategic Assessment BioLife Solutions, Thermo Fisher Scientific, GE Healthcare - KYT24 - November 14th, 2020
- The heart of a mouse embryo was first created from stem cells - FREE NEWS - November 11th, 2020
- Genetic Mechanism Identified in Neonatal Diabetes Could Offer Insights into Other Forms of the Disease - Genetic Engineering & Biotechnology News - November 11th, 2020
Recent Comments